A detailed history of Prosperity Consulting Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Prosperity Consulting Group, LLC holds 53,349 shares of MRK stock, worth $5.2 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
53,349
Previous 51,960 2.67%
Holding current value
$5.2 Million
Previous $6.43 Million 5.81%
% of portfolio
0.48%
Previous 0.89%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$111.15 - $128.97 $154,387 - $179,139
1,389 Added 2.67%
53,349 $6.06 Million
Q2 2024

Aug 08, 2024

SELL
$123.8 - $132.96 $535,930 - $575,583
-4,329 Reduced 7.69%
51,960 $6.43 Million
Q1 2024

May 01, 2024

BUY
$113.24 - $131.95 $4.46 Million - $5.2 Million
39,412 Added 233.52%
56,289 $7.43 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $415,045 - $451,669
4,143 Added 32.53%
16,877 $1.84 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $993,879 - $1.1 Million
9,654 Added 313.44%
12,734 $1.31 Million
Q2 2023

Jul 25, 2023

SELL
$108.61 - $118.38 $10,643 - $11,601
-98 Reduced 3.08%
3,080 $355,000
Q1 2023

Apr 24, 2023

SELL
$102.94 - $114.86 $4,220 - $4,709
-41 Reduced 1.27%
3,178 $338,000
Q4 2022

Feb 08, 2023

BUY
$87.44 - $112.11 $20,810 - $26,682
238 Added 7.98%
3,219 $357,000
Q3 2022

Oct 17, 2022

SELL
$84.53 - $94.96 $22,654 - $25,449
-268 Reduced 8.25%
2,981 $257,000
Q2 2022

Jul 25, 2022

SELL
$83.49 - $94.64 $9,851 - $11,167
-118 Reduced 3.5%
3,249 $296,000
Q1 2022

Apr 19, 2022

SELL
$73.51 - $82.4 $1,396 - $1,565
-19 Reduced 0.56%
3,367 $276,000
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $244,740 - $306,568
3,386 New
3,386 $278,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Prosperity Consulting Group, LLC Portfolio

Follow Prosperity Consulting Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosperity Consulting Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prosperity Consulting Group, LLC with notifications on news.